$6.69
0.192.92%
Pre-Market: Dec 20, 4:01 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Redhill Biopharma in recent months.
Browse guidance and forecast on all stocks.